Weight loss before treatment | |||||
---|---|---|---|---|---|
No weight loss | <=5% weight loss | >5-10% weight loss | >10% weight loss | p-value* | |
Sex = Female | 15 (46.9%) | 4 (12.5%) | 11 (34.4%) | 2 (6.2%) | 0.09 |
Sex = Male | 63 (37.7%) | 45 (26.9%) | 34 (20.4%) | 25 (15.0%) | |
WHO performance = 0 | 51 (44.3%) | 33 (28.7%) | 23 (20.0%) | 8 (7.0%) | 0.004 |
WHO performance > = 1 | 27 (32.1%) | 16 (19.0%) | 22 (26.2%) | 19 (22.6%) | |
Age < 50 years | 21 (38.2%) | 14 (25.5%) | 6 (10.9%) | 14 (25.5%) | 0.006 |
Age > = 50 years | 57 (39.6%) | 35 (24.3%) | 39 (27.1%) | 13 (9.0%) | |
Site = Hypopharynx | 21 (42.9%) | 10 (20.4%) | 16 (32.7%) | 2 (4.1%) | 0.04 |
Site = Other | 57 (38.0%) | 39 (26.0%) | 29 (19.3%) | 25 (16.7%) | |
T classification = cT1-2 | 21 (52.5%) | 9 (22.5%) | 9 (22.5%) | 1 (2.5%) | 0.06 |
T classification = cT3-4 | 57 (35.8%) | 40 (25.2%) | 36 (22.6%) | 26 (16.4%) | |
N classification = cN0-1 | 41 (50.0%) | 18 (22.0%) | 15 (18.3%) | 8 (9.8%) | 0.07 |
N classification = cN2-3 | 37 (31.6%) | 31 (26.5%) | 30 (25.6%) | 19 (16.2%) | |
Parenteral nutrition or feeding tube = No | 48 (39.0%) | 35 (28.5%) | 22 (17.9%) | 18 (14.6%) | 0.2 |
Parenteral nutrition or feeding tube = Yes | 30 (40.5%) | 14 (18.9%) | 22 (29.7%) | 8 (10.8%) | |
Hemoglobin > = 14 g/dL | 52 (48.1%) | 30 (27.8%) | 21 (19.4%) | 5 (4.6%) | <0.001 |
Hemoglobin < 14 g/dL | 26 (28.6%) | 19 (20.9%) | 24 (26.4%) | 22 (24.2%) |